Several international organizations in the hemp industry have released an update on the global position of hemp production and marketing. Led by the European Industrial Hemp Association (EIHA), the organizations released an 18-page update whose main highlight was that the hemp industry should not be subject to international drug laws as stipulated under the United Nations drug treaties.
The update calls for a transparent debate on the hemp laws and regulations that govern the industry on the international stage. From the report, industrial hemp is deemed as a valuable agricultural crop with multiple functions.
According to Lorenza Romanese, who is the Managing Director at EIHA, the fact that hemp has a botanical relationship with marijuana should not sentence it to its deathbed. He calls for relevant authorities to read the release to take proper and necessary action.
The common position paper comes at a time when several significant decisions that could change the hemp industry are set to be made in the near coming days in Europe and the UN. In December this year, a vote in the United Nations Commission on Narcotic Drugs (CND) is set to seal the fate of some issues concerning medical CBD which is commonly extracted from hemp. The US is already preparing for the Cannabidiol Enforcement Policy Draft Guidance by the FDA and the USDA’s Interim Final Rule.
The update by the international hemp organizations also seeks to push for countries to increase their legal hemp threshold from 0.3% to 1%. The groups claim the hemp plants with more than 0.3% THC also contain higher amounts of cannabidiol (CBD). They also argue that the tiny THC margin given by most countries is causing headaches for most farmers. Some countries that have adopted the 1% THC rule include Malawi, Uruguay, South Africa, Ecuador, and Thailand.